 BRIDGEWATER, N.J., Jan. 17, 2023 GLOBE NEWSWIRE -- Hillstream BioPharma, Inc. Nasdaq: HILS Hillstream or the Company, a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, will present at the Virtual Sidoti Micro-Cap Conference being held on January 18-19, 2023. 